These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10114005)

  • 1. How involved is hospital administration in your P & T Committee?
    Zar FA
    Hosp Formul; 1991 Sep; 26(9):739. PubMed ID: 10114005
    [No Abstract]   [Full Text] [Related]  

  • 2. The JCAH and the P&T Committee.
    Lipman AG
    Hosp Formul; 1985 Mar; 20(3):263. PubMed ID: 10289613
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased pressures change P & T Committee makeup.
    Cross M
    Manag Care; 2001 Dec; 10(12):18-9, 23-4, 27-30. PubMed ID: 11794998
    [No Abstract]   [Full Text] [Related]  

  • 4. Challenges of a P & T Committee in a community teaching hospital.
    Cooke DH; Kessler J
    Hosp Formul; 1990 Aug; 25(8):878-82, 886. PubMed ID: 10105706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The JCAHO Agenda for Change: what changes in pharmacy and P & T activities do you need to prepare for in 1994?
    Doherty EC
    Hosp Formul; 1994 Jan; 29(1):54-6, 58-60, 64 passim. PubMed ID: 10131267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective decision-making in a changing healthcare environment: a P & T Committee interview.
    Zoloth A; Yon JL; Woolf R
    Hosp Formul; 1989 Feb; 24(2):85-7, 90, 93 passim. PubMed ID: 10291815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In what ways does the pharmacy department actively participate in P & T Committee meetings?
    Wooten JM; Williams R; Merryfield D
    Hosp Formul; 1990 Nov; 25(11):1186. PubMed ID: 10107822
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse drug reaction reporting system: developing a well-monitored program.
    Kilarski DJ; Ziegler B; Coarse J; Buchanan C
    Hosp Formul; 1986 Sep; 21(9):949-52. PubMed ID: 10289704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to develop a successful DUE (drug usage evaluation) program: experience of a teaching medical center.
    Cheung MO
    Hosp Formul; 1994 Feb; 29(2):137-9, 142-3, 145. PubMed ID: 10131876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolution of an effective P & T Committee: advice from the chairman.
    Williams RR
    Hosp Formul; 1986 Dec; 21(12):1232-5, 1243. PubMed ID: 10279772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revised ADR report permits internal review of drug experience.
    Jeffrey LP
    Pharm Times; 1986 Dec; 52(12):48-50. PubMed ID: 10317827
    [No Abstract]   [Full Text] [Related]  

  • 12. P&T Committee overview: Brigham and Women's Hospital.
    Shea BF; Churchill WW; Powell SH; Cooley TW; Maguire JH
    Pharm Pract Manag Q; 1998 Jan; 17(4):76-83. PubMed ID: 10174751
    [No Abstract]   [Full Text] [Related]  

  • 13. ISMS guide to hospital medical staff bylaws.
    IMJ Ill Med J; 1984 May; 165(5):342-50. PubMed ID: 6145694
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparing your lab for an inspection.
    Hefner MS
    MLO Med Lab Obs; 1989 Aug; 21(8):37-40, 45, 47. PubMed ID: 10294492
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic review: the experience of one pharmacy and therapeutics committee.
    Kiepert DR
    QRB Qual Rev Bull; 1979 Jan; 5(1):24-7. PubMed ID: 121376
    [No Abstract]   [Full Text] [Related]  

  • 16. P & T Committee interview: strategies to ensure an effective formulary system.
    Riff L; Hutchinson R
    Hosp Formul; 1988 Nov; 23(11):901-4, 907-8. PubMed ID: 10290754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-assisted use of tracer antidote drugs to increase detection of adverse drug reactions: a retrospective and concurrent trial.
    Dalton-Bunnow MF; Halvachs FJ
    Hosp Pharm; 1993 Aug; 28(8):746-9, 752-5. PubMed ID: 10127575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing a more formal adverse drug reaction reporting system.
    Tse CS; Madura AJ
    Hosp Formul; 1992 Aug; 27(8):845-8. PubMed ID: 10119518
    [No Abstract]   [Full Text] [Related]  

  • 19. P & T Committee role in advocating rational therapeutics.
    Borreson R
    Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical staff bylaws are a contract: true, false or irrelevant?
    Hershey N
    Med Staff Couns; 1988; 2(3):13-21. PubMed ID: 10289835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.